SCHEMBL4129312

SCHEMBL4129312

CCN(C(=O)C=Cc1ccccc1)c1ccc(OC)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 8/20 0.74
NPC1 O15118 2/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
ALDH1A1 P00352 1/20 0.56
MAPT P10636 1/20 0.56
HSPD1 P10809 1/20 0.56
TNFRSF1A P19438 1/20 0.56
MAOB P27338 1/20 0.56
HSPE1 P61604 1/20 0.56
CYP1B1 Q16678 1/20 0.56
LMNA P02545 1/20 0.53
BCHE P06276 1/20 0.52
CYP3A4 P08684 1/20 0.52
NFKB1 P19838 1/20 0.52
NFKB2 Q00653 1/20 0.52
RELA Q04206 1/20 0.52
EGFR P00533 1/20 0.52
MMP1 P03956 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4129308 1.00 TRPM8 (0.74) TRPM8NPC1L3MBTL1MEN1KMT2A
SCHEMBL18536909 0.95 TRPM8 (0.83) TRPM8NPC1L3MBTL1MEN1KMT2A
SCHEMBL10270945 0.85 TRPM8 (1.00) TRPM8NPC1MEN1KMT2AALDH1A1
SCHEMBL12060510 0.85 NPC1 (0.60) TRPM8NPC1L3MBTL1MEN1KMT2A
SCHEMBL18575785 0.82 TRPM8 (0.84) TRPM8NPC1LMNABCHECYP3A4
SCHEMBL10270952 0.82 TRPM8 (1.00) TRPM8MEN1KMT2ALMNABCHE
SCHEMBL29779967 0.81 TRPM8 (0.77) TRPM8NPC1MEN1KMT2AALDH1A1
SCHEMBL20777273 0.81 TRPM8 (0.77) TRPM8NPC1MEN1KMT2AALDH1A1
SCHEMBL20250757 0.79 TRPM8 (0.68) TRPM8NPC1L3MBTL1KMT2AALDH1A1
SCHEMBL30532218 0.77 TRPM8 (1.00) TRPM8NPC1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247579-A1 2-[3H-THIAZOL-2-YLIDINEMETHYL]PYRIDINES AND RELATED COMPOUNDS AND THEIR USE CANCER RESEARCH TECHNOLOGY LIMITED 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247579-A1 2-[3H-THIAZOL-2-YLIDINEMETHYL]PYRIDINES AND RELATED COMPOUNDS AND THEIR USE RB1, RBBP5, RRM2B TRPM8 4506/4885NPC1 3790/4885L3MBTL1 1828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.